1. Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC)
- Author
-
Al-Daghmin, A, Kauffman, EC, Shi, Y, Badani, K, Balbay, MD, Canda, E, Dasgupta, P, Ghavamian, R, Grubb, R, Hemal, A, Kaouk, J, Kibel, AS, Maatman, T, Menon, M, Mottrie, A, Nepple, K, Pattaras, JG, Peabody, JO, Poulakis, V, Pruthi, R, Redorta, JP, Rha, KH, Richstone, L, Schanne, F, Scherr, DS, Siemer, S, Stockle, M, Wallen, EM, Weizer, A, Wiklund, P, Wilson, T, Wilding, G, Woods, M, and Guru, KA
- Subjects
Adult ,Aged, 80 and over ,Male ,IRCC ,efficacy ,Robotics ,Middle Aged ,robot-assisted ,Cystectomy ,Article ,Postoperative Complications ,Treatment Outcome ,Urinary Bladder Neoplasms ,Risk Factors ,bladder cancer ,Humans ,Female ,radical cystectomy ,Aged ,Retrospective Studies - Abstract
Objective To characterise the surgical feasibility and outcomes of robot-assisted radical cystectomy (RARC) for pathological T4 bladder cancer. Patients and Methods Retrospective evaluation of a prospectively maintained International Radical Cystectomy Consortium database was conducted for 1118 patients who underwent RARC between 2003 and 2012. We dichotomised patients based on pathological stage (10 days, and 90-day readmission were significantly associated with complications in pT4 patients. Meanwhile, BMI, LOS > 10 days, grade 3-5 complications, 90-day readmission, smoking, previous abdominal surgery and neoadjuvant chemotherapy were significantly associated with mortality in pT4 patients. On multivariate analysis, BMI was an independent predictor of complications in pT4 patients, but not for mortality. Conclusions RARC for pT4 bladder cancer is surgically feasible but entails significant morbidity and mortality. BMI was independent predictor of complications in pT4 patients.
- Published
- 2014